Substance P induces CCN1 expression via histone deacetylase activity in human colonic epithelial cells

American Journal of Pathology

Volumn 179, Issue 5, 2011, Pages 2315-2326

  Koon, Hon Wai ^a   Shih, David Q ^b   Hing, Tressia C ^a   Chen, Jeremy ^a   Ho, Samantha ^a   Zhao, Dezheng ^c   Targan, Stephan R ^b   Pothoulakis, Charalabos ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b CEDARS SINAI MEDICAL CENTER   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYSTEINE RICH PROTEIN 61; DEXTRAN SULFATE; HISTONE DEACETYLASE; HISTONE H3; NEUROKININ 1 RECEPTOR; SUBSTANCE P;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COLITIS; COLON MUCOSA; CONTROLLED STUDY; DEACETYLATION; ENZYME ACTIVITY; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; INTESTINE EPITHELIUM CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEPHOSPHORYLATION; PROTEIN EXPRESSION;

ANIMALS; BICYCLO COMPOUNDS, HETEROCYCLIC; CELLS, CULTURED; COLITIS; CYSTEINE-RICH PROTEIN 61; DEXTRAN SULFATE; ENZYME INHIBITORS; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITHELIAL CELLS; GREEN FLUORESCENT PROTEINS; HISTONE DEACETYLASES; HUMANS; IMMUNOHISTOCHEMISTRY; INTESTINAL MUCOSA; MALE; MICE; MICE, INBRED C57BL; NEOVASCULARIZATION, PHYSIOLOGIC; NEUROTRANSMITTER AGENTS; REAL-TIME POLYMERASE CHAIN REACTION; SUBSTANCE P; TRANSFECTION; WOUND HEALING;

EID: 80055009055     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2011.07.038     Document Type: Article

References (43)

1. M.M. Chang, and S.E. Leeman Isolation of a sialogogic peptide from bovine hypothalamic tissue and its characterization as substance P J Biol Chem 245 1970 4784 4790
2. P.W. Mantyh Neurobiology of substance P and the NK1 receptor J Clin Psychiatry 63 Suppl 11 2002 6 10
3. M. Costa, J.B. Furness, R. Franco, I. Llewellyn-Smith, R. Murphy, and A.M. Beardsley Substance P in nerve tissue in the gut Ciba Found Symp 1982 129 144
4. C.A. Maggi Capsaicin-sensitive nerves in the gastrointestinal tract Arch Int Pharmacodyn Ther 303 1990 157 166
5. K.L. Bost Quantification of macrophage-derived substance P receptor mRNA using competitive polymerase chain reaction Adv Exp Med Biol 373 1995 219 223
6. C. Pothoulakis, I. Castagliuolo, J.T. LaMont, A. Jaffer, J.C. O'Keane, R.M. Snider, and S.E. Leeman CP-96,345, a substance P antagonist, inhibits rat intestinal responses to Clostridium difficile toxin A but not cholera toxin Proc Natl Acad Sci USA 91 1994 947 951
7. M. Riegler, I. Castagliuolo, P.T. So, M. Lotz, C. Wang, M. Wlk, T. Sogukoglu, E. Cosentini, G. Bischof, G. Hamilton, B. Teleky, E. Wenzl, J.B. Matthews, and C. Pothoulakis Effects of substance P on human colonic mucosa in vitro Am J Physiol 276 1999 G1473 G1483
8. P. Holzer, and U. Holzer-Petsche Tachykinins in the gut Part I. Expression, release and motor function Pharmacol Ther 73 1997 173 217
9. H.W. Koon, and C. Pothoulakis Immunomodulatory properties of substance P: the gastrointestinal system as a model Ann N Y Acad Sci 1088 2006 23 40
10. H.W. Koon, D. Zhao, Y. Zhan, S.H. Rhee, M.P. Moyer, and C. Pothoulakis Substance P stimulates cyclooxygenase-2 and prostaglandin E2 expression through JAK-STAT activation in human colonic epithelial cells J Immunol 176 2006 5050 5059
11. H.W. Koon, D. Zhao, Y. Zhan, S. Simeonidis, M.P. Moyer, and C. Pothoulakis Substance P-stimulated interleukin-8 expression in human colonic epithelial cells involves protein kinase Cdelta activation J Pharmacol Exp Ther 314 2005 1393 1400
12. D. Zhao, S. Kuhnt-Moore, H. Zeng, A. Pan, J.S. Wu, S. Simeonidis, M.P. Moyer, and C. Pothoulakis Substance P-stimulated interleukin-8 expression in human colonic epithelial cells involves Rho family small GTPases Biochem J 368 2002 665 672
13. I. Castagliuolo, O. Morteau, A.C. Keates, L. Valenick, C.C. Wang, J. Zacks, B. Lu, N.P. Gerard, and C. Pothoulakis Protective effects of neurokinin-1 receptor during colitis in mice: role of the epidermal growth factor receptor Br J Pharmacol 136 2002 271 279
14. H.W. Koon, D. Zhao, X. Na, M.P. Moyer, and C. Pothoulakis Metalloproteinases and transforming growth factor-alpha mediate substance P-induced mitogen-activated protein kinase activation and proliferation in human colonocytes J Biol Chem 279 2004 45519 45527
15. H.W. Koon, D. Zhao, Y. Zhan, M.P. Moyer, and C. Pothoulakis Substance P mediates antiapoptotic responses in human colonocytes by Akt activation Proc Natl Acad Sci USA 104 2007 2013 2018
16. H.W. Koon, D. Zhao, H. Xu, C. Bowe, A. Moss, M.P. Moyer, and C. Pothoulakis Substance P-mediated expression of the pro-angiogenic factor CCN1 modulates the course of colitis Am J Pathol 173 2008 400 410
17. D.R. Brigstock The CCN family: a new stimulus package J Endocrinol 178 2003 169 175
18. E.E. Moussad, and D.R. Brigstock Connective tissue growth factor: what's in a name? Mol Genet Metab 71 2000 276 292
19. D.R. Brigstock Regulation of angiogenesis and endothelial cell function by connective tissue growth factor (CTGF) and cysteine-rich 61 (CYR61) Angiogenesis 5 2002 153 165
20. F.E. Mo, A.G. Muntean, C.C. Chen, D.B. Stolz, S.C. Watkins, and L.F. Lau CYR61 (CCN1) is essential for placental development and vascular integrity Mol Cell Biol 22 2002 8709 8720
21. Y. Zhang, H. Fang, J. Jiao, and W. Xu The structure and function of histone deacetylases: the target for anti-cancer therapy Curr Med Chem 15 2008 2840 2849
22. A. Miremadi, M.Z. Oestergaard, P.D. Pharoah, and C. Caldas Cancer genetics of epigenetic genes Hum Mol Genet 16 Spec No 1 2007 R28 R49
23. E.I. Campos, and D. Reinberg Histones: annotating chromatin Annu Rev Genet 43 2009 559 599
24. B. Perez-Cadahia, B. Drobic, and J.R. Davie H3 phosphorylation: dual role in mitosis and interphase Biochem Cell Biol 87 2009 695 709
25. R. Glauben, A. Batra, I. Fedke, M. Zeitz, H.A. Lehr, F. Leoni, P. Mascagni, G. Fantuzzi, C.A. Dinarello, and B. Siegmund Histone hyperacetylation is associated with amelioration of experimental colitis in mice J Immunol 176 2006 5015 5022
26. L. Mayer, and R. Shlien Evidence for function of Ia molecules on gut epithelial cells in man J Exp Med 166 1987 1471 1483
27. H.S. Cooper, S.N. Murthy, R.S. Shah, and D.J. Sedergran Clinicopathologic study of dextran sulfate sodium experimental murine colitis Lab Invest 69 1993 238 249
28. R. Ungaro, M. Fukata, D. Hsu, Y. Hernandez, K. Breglio, A. Chen, R. Xu, J. Sotolongo, C. Espana, J. Zaias, G. Elson, L. Mayer, M. Kosco-Vilbois, and M.T. Abreu A novel Toll-like receptor 4 antagonist antibody ameliorates inflammation but impairs mucosal healing in murine colitis Am J Physiol Gastrointest Liver Physiol 296 2009 G1167 G1179
29. M.A. Halili, M.R. Andrews, M.J. Sweet, and D.P. Fairlie Histone deacetylase inhibitors in inflammatory disease Curr Top Med Chem 9 2009 309 319
30. L. Zhang, S. Jin, C. Wang, R. Jiang, and J. Wan Histone deacetylase inhibitors attenuate acute lung injury during cecal ligation and puncture-induced polymicrobial sepsis World J Surg 34 2010 1676 1683
31. I. Rahman, J. Marwick, and P. Kirkham Redox modulation of chromatin remodeling: impact on histone acetylation and deacetylation, NF-kappaB and pro-inflammatory gene expression Biochem Pharmacol 68 2004 1255 1267
32. T. Goode, J. O'Connell, P. Anton, H. Wong, J. Reeve, G.C. O'Sullivan, J.K. Collins, and F. Shanahan Neurokinin-1 receptor expression in inflammatory bowel disease: molecular quantitation and localisation Gut 47 2000 387 396
33. E. Wegel, and P. Shaw Gene activation and deactivation related changes in the three-dimensional structure of chromatin Chromosoma 114 2005 331 337
34. Z. Chen, S. Clark, M. Birkeland, C.M. Sung, A. Lago, R. Liu, R. Kirkpatrick, K. Johanson, J.D. Winkler, and E. Hu Induction and superinduction of growth arrest and DNA damage gene 45 (GADD45) alpha and beta messenger RNAs by histone deacetylase inhibitors trichostatin A (TSA) and butyrate in SW620 human colon carcinoma cells Cancer Lett 188 2002 127 140
35. H. Nian, B. Delage, E. Ho, and R.H. Dashwood Modulation of histone deacetylase activity by dietary isothiocyanates and allyl sulfides: studies with sulforaphane and garlic organosulfur compounds Environ Mol Mutagen 50 2009 213 221
36. Kai L, Samuel SK, Levenson AS: Resveratrol enhances p53 acetylation and apoptosis in prostate cancer by inhibiting MTA1/NuRD complex. Int J Cancer 126:1538-1548
37. J. Hu, and N.H. Colburn Histone deacetylase inhibition down-regulates cyclin D1 transcription by inhibiting nuclear factor-kappaB/p65 DNA binding Mol Cancer Res 3 2005 100 109
38. R. Furumai, A. Ito, K. Ogawa, S. Maeda, A. Saito, N. Nishino, S. Horinouchi, and M. Yoshida Histone deacetylase inhibitors block nuclear factor-kappaB-dependent transcription by interfering with RNA polymerase II recruitment Cancer Sci 102 2011 1081 1087
39. R.H. Dashwood, M.C. Myzak, and E. Ho Dietary HDAC inhibitors: time to rethink weak ligands in cancer chemoprevention? Carcinogenesis 27 2006 344 349
40. J. O'Kelly, A. Chung, N. Lemp, K. Chumakova, D. Yin, H.J. Wang, J. Said, D. Gui, C.W. Miller, B.Y. Karlan, and H.P. Koeffler Functional domains of CCN1 (Cyr61) regulate breast cancer progression Int J Oncol 33 2008 59 67
41. I. Castagliuolo, L. Valenick, J. Liu, and C. Pothoulakis Epidermal growth factor receptor transactivation mediates substance P-induced mitogenic responses in U-373 MG cells J Biol Chem 275 2000 26545 26550
42. A.F. Stucchi, K.O. Shebani, S.E. Leeman, C.C. Wang, K.L. Reed, A.B. Fruin, A.C. Gower, J.P. McClung, C.D. Andry, M.J. O'Brien, C. Pothoulakis, and J.M. Becker A neurokinin 1 receptor antagonist reduces an ongoing ileal pouch inflammation and the response to a subsequent inflammatory stimulus Am J Physiol Gastrointest Liver Physiol 285 2003 G1259 G1267
43. H.W. Koon, D. Shih, I. Karagiannides, D. Zhao, Z. Fazelbhoy, T. Hing, H. Xu, B. Lu, N. Gerard, and C. Pothoulakis Substance P modulates colitis-associated fibrosis Am J Pathol 177 2010 2300 2309